For: | Falco A, Leiva M, Blanco A, Cefarelli G, Rodriguez A, Melo J, Cayol F, Rizzo MM, Sola A, Rodríguez Montani H, Chacon M, Enrico D, Waisberg F. First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer: A multicenter cohort study. World J Clin Oncol 2022; 13(2): 147-158 [PMID: 35316930 DOI: 10.5306/wjco.v13.i2.147] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v13/i2/147.htm |
Number | Citing Articles |
1 |
Christopher M. Black, Dandan Zheng, Gleicy M. Hair, Lei Ai, Liya Wang, Daisuke Goto, Nati Lerman, Behzad Bidadi, Glenn J. Hanna. Real-world use of first-line pembrolizumab + platinum + taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1348045
|
2 |
Akhina Palollathil, Revathy Nandakumar, Mukhtar Ahmed, Anoop Kumar G. Velikkakath, Mahammad Nisar, Muhammad Nisar, Rex Devasahayam Arokia Balaya, Sakshi Sanjay Parate, Vidyarashmi Hanehalli, Althaf Mahin, Rohan Thomas Mathew, Rohan Shetty, Jalaluddin Akbar Kandel Codi, Amjesh Revikumar, Manavalan Vijayakumar, Thottethodi Subrahmanya Keshava Prasad, Rajesh Raju. HNCDrugResDb: a platform for deciphering drug resistance in head and neck cancers. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-75861-9
|
3 |
Mafalda Calheiros-Lobo, João P. N. Silva, Bárbara Pinto, Luís Monteiro, Patrícia M. A. Silva, Hassan Bousbaa. Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer. Pharmaceutics 2024; 16(9): 1196 doi: 10.3390/pharmaceutics16091196
|
4 |
Ai-Ho Liao, Yu-An Lee, Dao-Lung Lin, Ho-Chiao Chuang, Jehng-Kang Wang, Ching-En Chang, Hsiang-Tzu Li, Ting-Yi Wu, Cheng-Ping Shih, Chih-Hung Wang, Yueng-Hsiang Chu. Treatment efficacy of low-dose 5-fluorouracil with ultrasound in mediating 5-fluorouracil-loaded microbubble cavitation in head and neck cancer. Drug Delivery 2023; 30(1): 1 doi: 10.1080/10717544.2022.2154410
|